Rates of Neonatal Abstinence Syndrome Amid Efforts to Combat the Opioid Abuse Epidemic.
Institute for Pharmaceutical Outcomes and Policy, Department of Pharmacy Practice and Sciences, University of Kentucky College of Pharmacy, Lexington.
Joshua D
JD
Brown
Institute for Pharmaceutical Outcomes and Policy, Department of Pharmacy Practice and Sciences, University of Kentucky College of Pharmacy, Lexington.
Pratik A
PA
Doshi
Institute for Pharmaceutical Outcomes and Policy, Department of Pharmacy Practice and Sciences, University of Kentucky College of Pharmacy, Lexington.
Nathan J
NJ
Pauly
Institute for Pharmaceutical Outcomes and Policy, Department of Pharmacy Practice and Sciences, University of Kentucky College of Pharmacy, Lexington.
Jeffery C
JC
Talbert
D006801:Humans; D013287:Illicit Drugs; D015994:Incidence; D007231:Infant, Newborn; D007629:Kentucky / Q000453:epidemiology; D009357:Neonatal Abstinence Syndrome / Q000453:epidemiology*; D009293:Opioid-Related Disorders / Q000453:epidemiology* / Q000517:prevention & control; D063487:Prescription Drug Misuse / Q000706:statistics & numerical data; D014481:United States / Q000453:epidemiology
D013287:Illicit Drugs
JAMA. 2012 May 9;307(18):1934-40
22546608
Pediatrics. 2012 Feb;129(2):e540-60
22291123
J Pediatr. 2015 Dec;167(6):1189-91
26454574
Am J Public Health. 2014 Feb;104(2):e52-9
24328642
N Engl J Med. 2015 Jan 15;372(3):241-8
25587948